HARBOURVEST PARTNERS LLC Quant / Systematic

CIK: 0001201001 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $255,903 (100.0% shares, 0.0% debt)

Holdings (26)

Solarwinds Corp. 43.5%
Value ($000) $111,216 Shares 7,439,200 Est. Cost $13.83 Unrealized
Evelo Biosciences, Inc. 14.5%
Value ($000) $37,038 Shares 3,063,505 Est. Cost $8.87 Unrealized
Sigilon Therapeutics, Inc. 13.9%
Value ($000) $35,578 Shares 740,740 Est. Cost $48.03 Unrealized
KLDO Kaleido BioSciences, Inc. 6.5%
Value ($000) $16,688 Shares 1,833,832 Est. Cost $11.01 Unrealized -25.5%
Axcella Health, Inc. 5.7%
Value ($000) $14,573 Shares 2,807,981 Est. Cost $7.18 Unrealized
TDOC TelaDoc Health, Inc. 4.0%
Value ($000) $10,187 Shares 50,943 Est. Cost $211.77 Unrealized -4.0%
Rubius Therapeutics, Inc. 2.9%
Value ($000) $7,490 Shares 986,878 Est. Cost $24.00 Unrealized
LC LendingClub Corp. 2.1%
Value ($000) $5,422 Shares 513,440 Est. Cost $12.90 Unrealized -48.2%
Spark Networks SE 1.0%
Value ($000) $2,674 Shares 502,576 Est. Cost $5.53 Unrealized
Slack Technologies, Inc. 1.0%
Value ($000) $2,578 Shares 61,037 Est. Cost $42.24 Unrealized
Zuora, Inc. 0.9%
Value ($000) $2,283 Shares 163,894 Est. Cost $18.77 Unrealized
Seres Therapeutics, Inc. 0.8%
Value ($000) $2,056 Shares 83,903 Est. Cost $24.50 Unrealized
YEXT Yext, Inc. 0.7%
Value ($000) $1,810 Shares 115,147 Est. Cost $22.86 Unrealized -25.2%
Adverum Biotechnologies, Inc. 0.6%
Value ($000) $1,454 Shares 134,154 Est. Cost $10.84 Unrealized
PGNY Progyny, Inc. 0.5%
Value ($000) $1,261 Shares 29,743 Est. Cost $27.57 Unrealized +18.0%
AR Antero Resources LLC 0.3%
Value ($000) $719 Shares 131,895 Est. Cost $7.21 Unrealized -43.1%
CTMX Cytomx Therapeutics, Inc. 0.2%
Value ($000) $519 Shares 79,193 Est. Cost $25.54 Unrealized -72.0%
Trevena, Inc. 0.2%
Value ($000) $500 Shares 233,850 Est. Cost $6.45 Unrealized
Castlight Health, Inc. 0.2%
Value ($000) $454 Shares 349,070 Est. Cost $2.63 Unrealized
Yumanity 0.1%
Value ($000) $375 Shares 22,030 Est. Cost $17.02 Unrealized
XGN Exagen, Inc. 0.1%
Value ($000) $343 Shares 25,982 Est. Cost $19.85 Unrealized -28.8%
Epizyme, Inc. 0.1%
Value ($000) $268 Shares 24,686 Est. Cost $16.04 Unrealized
Rapt Therapeutics, Inc. 0.1%
Value ($000) $244 Shares 12,351 Est. Cost $19.76 Unrealized
NextCure, Inc. 0.0%
Value ($000) $109 Shares 10,044 Est. Cost $37.04 Unrealized
Ramaco Resources, Inc. 0.0%
Value ($000) $43 Shares 14,951 Est. Cost $5.80 Unrealized
HNRG Hallador Energy Resources, Inc. 0.0%
Value ($000) $21 Shares 14,270 Est. Cost $5.36 Unrealized -82.9%